Família Anticorpo para Carcinoma de Pele e Melanoma

Immunohistochemistry - skin carcinoma and melanoma markers · class III · Until 23/11/2030

Registration no.
10337990046
Process no.
25351311163202018
Status
Until 23/11/2030
Device type
Immunohistochemistry - skin carcinoma and melanoma markers (IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS)
Risk class
III
Registration holder
LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. CNPJ 52.201.456/0001-13 · 90 registrations
Manufacturer
LEICA BIOSYSTEMS NEWCASTLE LTD · United Kingdom
Published
23/11/2020
Valid until
23/11/2030
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other immunohistochemistry - skin carcinoma and melanoma markers registrations (8 in total, see all)

ProductClass HolderPublishedStatus
SOX-10 (SP267) Rabbit Monoclonal Primary Antibody
10287411764
III ROCHE DIAGNÓSTICA BRASIL LTDA 22/09/2025 Until 22/09/2035
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
10287411678
III ROCHE DIAGNÓSTICA BRASIL LTDA 23/10/2023 Until 23/10/2033
Melanoma Triple Coktail (HMB45+A103+T311)
10287411453
III ROCHE DIAGNÓSTICA BRASIL LTDA 21/10/2019 Until 21/10/2029
Marcador de Carcinoma de Pele e Melanona
80000230032
III AGILENT TECHNOLOGIES BRASIL LTDA 26/12/2016 Until 17/03/2034
Família Marcador de Carcinoma de Pele e Melanona
80000230073
III AGILENT TECHNOLOGIES BRASIL LTDA 26/12/2016 Until 27/07/2035
Família de Câncer de Pele
10287411082
III ROCHE DIAGNÓSTICA BRASIL LTDA 02/02/2015 Until 02/02/2035
Familia Cancer de Pele e Melanomas
10287410787
III ROCHE DIAGNÓSTICA BRASIL LTDA 18/05/2009 Until 18/05/2034